MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference
- 30 June 1991
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 39 (2) , 509-512
- https://doi.org/10.1016/0091-3057(91)90217-p
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beveragePharmacology Biochemistry and Behavior, 1990
- Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preferencePharmacology Biochemistry and Behavior, 1990
- Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine releaseBrain Research Bulletin, 1989
- 5HT3 receptor antagonists block morphine- and nicotine-but not amphetamine-induced rewardPsychopharmacology, 1989
- Activation of a 5-HT3 receptor releases dopamine from rat striatal sliceEuropean Journal of Pharmacology, 1988
- Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sitesEuropean Journal of Pharmacology, 1988
- Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brainBritish Journal of Pharmacology, 1987
- Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brainEuropean Journal of Pharmacology, 1987
- Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboonPsychopharmacology, 1987
- Neural basis of psychomotor stimulant and opiate reward: Evidence suggesting the involvement of a common dopaminergic systemBehavioural Brain Research, 1986